How a Milk-Derived Peptide Kills Candida Fungal Infections | Research

The takeaway

LfcinB15, a lactoferricin-derived peptide, kills Candida albicans through multiple mechanisms including membrane disruption, reactive oxygen species generation, and mitochondrial dysfunction.

Triple killing mechanism
Membrane disruption, ROS generation, and mitochondrial dysfunction work together against Candida

What the researchers found

LfcinB15 kills Candida albicans through at least three mechanisms: membrane disruption, ROS generation, and mitochondrial dysfunction, while activating Hog1 and Mkc1 stress-response kinases.

Why it matters

Candida infections are increasingly resistant to conventional antifungal drugs. Understanding how antimicrobial peptides kill fungi through multiple simultaneous mechanisms could help develop new antifungal strategies that are harder for pathogens to resist.

The numbers in context

Active vs planktonic + biofilm C. albicans + clinical isolates + non-albicans; membrane disruption; ROS generation; mitochondrial dysfunction; Hog1 + Mkc1 activated

How the study worked

In vitro susceptibility testing against planktonic and biofilm cells. Fluorescence microscopy for peptide localization. Membrane integrity assays, ROS detection, mitochondrial function assessment, and Western blot for MAPK activation in C. albicans.

Who was studied

Candida albicans (planktonic, biofilm, clinical isolates) and non-albicans Candida species

What this study cannot tell us

In vitro study only. No animal infection model data. Peptide stability and efficacy in vivo not tested. Specific MIC values not reported in abstract.

How to read the evidence

Thorough in vitro mechanistic study with multiple complementary assays. Provides strong mechanistic evidence but lacks in vivo validation.

When this study was published

Published in 2021, contributing to understanding of antimicrobial peptide mechanisms against priority fungal pathogens.

The bigger picture

Antifungal resistance is a growing concern, with the WHO listing Candida species among priority fungal pathogens. Antimicrobial peptides with multiple killing mechanisms are less likely to encounter resistance than single-target drugs, making them promising alternatives.

Questions still open

Would LfcinB15 be effective in animal models of Candida infection?
Could resistance develop against multi-mechanism peptides like LfcinB15?
How does LfcinB15 compare to conventional antifungals in biofilm eradication?

Common questions

What is LfcinB15 and where does it come from?

LfcinB15 is a peptide derived from bovine lactoferricin, which itself comes from lactoferrin — a protein found in cow's milk. It has been designed as a shorter, more potent version of the natural antimicrobial peptide.

Why use peptides instead of standard antifungal drugs?

Standard antifungal drugs typically attack one target, making it easier for fungi to develop resistance. LfcinB15 kills Candida through at least three different mechanisms simultaneously — disrupting the cell membrane, generating toxic oxygen species, and damaging mitochondria — making resistance much harder to develop.

Read the original research

Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans.

Journal of fungi (Basel, Switzerland), 7(7)

View on PubMed ↗Publisher’s paper ↗

Citation

Chang, Che-Kang; Kao, Mou-Chieh; Lan, Chung-Yu. (2021). Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans.. Journal of fungi (Basel, Switzerland), 7(7). https://doi.org/10.3390/jof7070519